Insights

Dr Raymond Cross quizzes Dr Francis Farraye on the latest guidance regarding vaccinations against COVID-19 and RSV in this episode of IBD DriveTime.

Dr Loftus, from Mayo Clinic in Rochester, Minnesota, reviews results from the phase 3 INSPIRE trial of risankizumab for induction of remission among patients with moderate to severe ulcerative colitis.

Dr Krugliak Cleveland discusses her award-winning oral presentation on how the use of intestinal ultrasound can quickly identify inflammation among patients with IBD, helping to shorten the time to a change of therapy and enabling faster...

Dr Kane reviews her presentation at the ACG Postgraduate Meeting. on accurately diagnosing moderate, severe, or refractory Crohn's disease, and the many treatment options now available for these patients. 

Dr Regueiro reviews his presentation on positioning therapies for IBD from the session on pathophysiology at the American College of Gastroenterology postgraduate course on October 21 in Vancouver.

In this episode of IBD Drive Time, guest host David Rubin, MD, calls on Drs Severine Vermeire of KU Leuven University in Belgium and Dan Tucker of Hebrew University of Jerusalem to talk about the challenges of recruiting patients for clinical...

Guest Michael Dolinger, MD, from the Icahn School of Medicine at Mount Sinai, talks to host Millie Long, MD, about the use and advantages of intestinal ultrasound for monitoring inflammatory bowel disease.